Biochemical Reagent
-
BA6558 BCRP-IN-1Summary: BCRP-IN-1 is a potent inhibitor of drug-resistant proteins in breast cancer. - BA6559 ML753286Summary: ML753286 is an orally active and selective (anti-breast cancer protein) inhibitor.
- BA6560 ML230Summary: ML230 (CID44640177; SID88095709) is a selective inhibitor of the ATP-binding transporter factor isoform.
- BA6561 YHO-13351Summary: YHO-13351 is the precursor drug of YHO-13177.
- BA6562 Ac32Az19Summary: Ac32Az19 is a potent, nontoxic, and highly selective BCRP inhibitor.
- BA6563 CCTA-1523Summary: CCTA-1523 is a potent, selective, reversible and orally active inhibitor.
- BA6564 VerapamilSummary: Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent orally active first-generation P glycoprotein inhibitor.
- BA6565 TPC2-A1-NSummary: TPC2-A1-N is a potent agonist of Ca-permeable two-pore channel 2 that acts by mimicking the physiological effects of NAADP.
- BA6566 GSK-7975ASummary: Highly potent orally active channel inhibitor.
- BA6567 N106Summary: N106 is the first activator of the sarcoplasmic reticulum calcium ATPase SUMOylation.